Akero Therapeutics Inc (AKRO)
29.76
-1.21
(-3.91%)
USD |
NASDAQ |
Nov 14, 16:00
29.02
-0.74
(-2.49%)
After-Hours: 20:00
Akero Therapeutics Cash from Financing (Quarterly): 3.067M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.067M |
| June 30, 2024 | -0.15M |
| March 31, 2024 | 366.94M |
| December 31, 2023 | 0.502M |
| September 30, 2023 | 0.806M |
| June 30, 2023 | 336.86M |
| March 31, 2023 | 15.15M |
| December 31, 2022 | 2.723M |
| September 30, 2022 | 217.90M |
| June 30, 2022 | 34.88M |
| March 31, 2022 | 0.132M |
| December 31, 2021 | 0.243M |
| September 30, 2021 | 0.069M |
| June 30, 2021 | 0.266M |
| Date | Value |
|---|---|
| March 31, 2021 | 0.024M |
| December 31, 2020 | 0.059M |
| September 30, 2020 | 202.78M |
| June 30, 2020 | 0.10M |
| March 31, 2020 | 0.164M |
| December 31, 2019 | 0.115M |
| September 30, 2019 | -1.607M |
| June 30, 2019 | 98.20M |
| March 31, 2019 | -0.72M |
| December 31, 2018 | 70.22M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 14.78M |
| March 31, 2018 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.15M
Minimum
Jun 2024
366.94M
Maximum
Mar 2024
59.13M
Average
0.384M
Median
Cash from Financing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 7.462M |
| 89bio Inc | 33.19M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | 5.991M |
| iBio Inc | 12.99M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.42M |
| Cash from Investing (Quarterly) | 73.07M |
| Free Cash Flow | -212.64M |
| Free Cash Flow Per Share (Quarterly) | -1.014 |
| Free Cash Flow Yield | -11.27% |